Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Amylin Pharmaceuticals Incorporated published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-6 of 6
» View ktuu.com items only
    Jul 16, 2012 |Story| Baltimore Sun

  1. GlaxoSmithKline to acquire Human Genome Sciences

    After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion.
    After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion. GlaxoSmithKline boosted its offer for...

    Tags: Biotechnology, Benlysta (drug), Patents, Copyrights and Trademarks, Diabetes, Bristol Myers Squibb Company

    2. Oct 18, 2010 |Story| Chicago Tribune

  2. Some drugs raising red flags

    At drug company-sponsored seminars, Illinois doctors are speaking about dozens of commonly prescribed medications that help millions of patients. But questions have been raised about some of the drugs: •Atypical antipsychotics such as Zyprexa (...

    Tags: Allergies, Health, Lilly Eli & Co, Health and Medical Professionals, Diabetes

    3. Jul 23, 2006 |Story| Chicago Tribune

  3. The week ahead

    Chicago Tribune
    Monday: -- Earnings: Altera Corp.; American Express Co.; Amylin Pharmaceuticals Inc.; Avaya Inc.; BellSouth Corp.; Centex Corp.; Kraft Foods Inc.; Pactiv Corp.; Quest Diagnostics Inc.; SanDisk Corp.; Texas Instruments Inc. Tuesday: -- July consumer...

    Tags: Pactiv Corporation, MBIA Incorporated, Colgate-Palmolive Company, Air Transportation Industry, Kraft Foods Group, Inc.

    4. Jun 21, 2007 |Story| Chicago Tribune

  4. Diabetes pill's sales health in question

    Heading into this weekend's American Diabetes Association meeting in Chicago, industry analysts are predicting a continued decline of the diabetes pill Avandia. Avandia, sold by British drug giant GlaxoSmithKline PLC, has been losing market share in...

    Tags: Obesity, Avandia (drug), Health, Novartis AG, Medical Research

    5. Jun 17, 2007 |Story| Tribune Media Services
  5. |Story

    Tags: Career and Workplace, Health, Charity, China, Insurance

    6. Aug 26, 2008 |Story| WXIN-LTV

  6. Companies report 4 new deaths with diabetes drug

    Eli Lilly and Amylin Pharmaceuticals report four new deaths in patients taking the diabetes medication Byetta. An executive from Indianapolis-based Eli Lilly says the FDA is aware of the additional deaths but did not announce them because they involved...

    Tags: Health, Drugs and Medicines, Lilly Eli & Co, Pharmaceuticals, Diabetes

Original site for Amylin Pharmaceuticals Incorporated topic gallery.